Immunoinformatics Approach Identified Two Highly Conserved B and T Cell Epitopes, LEASKRWAF and DSPLEASKRWAFRTG, for Effective Vaccine Design against Ebola and Marburg Viruses

References (41)

1. 1 MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0 [DOI]
2. 2 MUSCLE: multiple sequence alignment with high accuracy and high throughput [DOI]
3. 3 AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading [DOI]
4. 4 VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines [DOI]
5. 5 Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research [DOI]
6. 6 BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes [DOI]
7. 7 New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and x-ray-derived accessible sites [DOI]
8. 8 Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp [DOI]
9. 9 Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor [DOI]
10. 10 Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats [DOI]
11. 11 Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection [DOI]
12. 12 Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method [DOI]
13. 13 Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines [DOI]
14. 14 A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection [DOI]
15. 15 Immune epitope database analysis resource [DOI]
16. 16 Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody [DOI]
17. 17 Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates [DOI]
18. 18 Ebola Virus VP24 Targets a Unique NLS Binding Site on Karyopherin Alpha 5 to Selectively Compete with Nuclear Import of Phosphorylated STAT1 [DOI]
19. 19 An introduction to epitope prediction methods and software [DOI]
20. 20 Filoviruses are ancient and integrated into mammalian genomes [DOI]
21. 21 Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates [DOI]
22. 22 Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus [DOI]
23. 23 Fully automated antibody structure prediction using BIOVIA tools: Validation study [DOI]
24. 24 Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012 [DOI]
25. 25 Structural basis for Marburg virus VP35–mediated immune evasion mechanisms [DOI]
26. 26 Ebola and Marburg virus vaccines [DOI]
27. 27 Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis [DOI]
28. 28 Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection [DOI]
29. 29 Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody [DOI]
30. 30 Integrating Clinical Research into Epidemic Response [DOI]
31. 31 Two-mAb cocktail protects macaques against the Makona variant of Ebola virus [DOI]
32. 32 Deep Sequencing Identifies Noncanonical Editing of Ebola and Marburg Virus RNAs in Infected Cells [DOI]
33. 33 BEST: Improved Prediction of B-Cell Epitopes from Antigen Sequences [DOI]
34. 34 Computational prediction of N-linked glycosylation incorporating structural properties and patterns [DOI]
35. 35 Filovirus proteins for antiviral drug discovery: A structure/function analysis of surface glycoproteins and virus entry [DOI]
36. 36 Host and Viral Proteins Modulating Ebola and Marburg Virus Egress [DOI]
37. 37 Comparative Proteomics Profile of Lipid-Cumulating Oleaginous Yeast: An iTRAQ-Coupled 2-D LC-MS/MS Analysis [DOI]
38. 38 Complete protection of the BALB/c and C57BL/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine [DOI]
39. 39 Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease [DOI]
40. 40 Ebola and Marburg Viruses: Molecular and Cellular Biology
41. 41 Predicting transmembrane protein topology with a hidden markov model: application to complete genomes11Edited by F. Cohen [DOI]

Cited by 4

Showing 1 of 4 known citations — external sources report more than can currently be individually listed.

Related research

• Online Information Seeking Behavior among Indonesian during the COVID-19 Pandemic — shares topic coverage
• Determinants of COVID-19 Vaccine Uptake among Health Care Workers: A Case Study of Mogadishu City, Somalia — shares topic coverage
• Assessment of Hepatitis B Vaccine Efficacy, Prevalence of Infection, and Risk Determinants among Expectant Mothers at Antenatal Care in Abyei, South Sudan — shares topic coverage
• Preparation of Fowl Typhoid Vaccine from Field Isolates and Determination of Efficacy — shares topic coverage
• Protection against Helicobacter pylori Infection in BALB/c Mice by Oral or Intramuscular Administration of Multicomponent Vaccine of rCagA +LPS +CpG — shares topic coverage